| This article is part of our series on Custom Medical Billing and Denial Management Platform Development for US RCM Companies: Building an Automated Claims, Remittance and Appeals Workflow |
Intro: The Decision Is Not Build or Buy. It Is Which Layers.
Framed as RCM software build vs buy, this decision has no good answer. Building an entire platform including transaction translation is an expensive way to reinvent infrastructure that already works. Buying an entire platform means competing with every other billing company using the same tools.
Framed layer by layer, it resolves quickly. Transaction handling, clearinghouse connectivity, and code set data are plumbing. The denial workflow, queue economics, client experience, and operating model are what the company actually sells.
Most billing companies that should build something should build considerably less than they initially plan. The value of proper custom claims platform scoping is in establishing where that line falls. This article covers what existing platforms do well, where they break, the hybrid position, the decisions that destroy budgets, and what a custom software development scoping engagement should produce for a claims workflow application development project.
What Existing RCM Platforms Genuinely Do Well
Established platforms solve a great deal, and a medical billing technology consultant who cannot say so plainly is selling rather than advising.
They arrive with transaction handling that already works across claim types and payer quirks accumulated over years. They carry existing clearinghouse relationships and payer connectivity, removing months of integration and enrollment work. They track regulatory change as part of the subscription, which in this industry is a standing job rather than an occasional update.
They are supported, proven against volume, and operating within weeks.
For a billing company under a few dozen staff running conventional service lines, that combination is usually decisive. A company in that position should be told so directly rather than encouraged toward a build it will struggle to finish. The honest question is not whether these platforms are good. It is whether the parts a company most needs to differentiate are the parts the platform holds most rigidly.
Where They Break for a Billing Company Specifically
Most platforms were designed for a provider organization managing its own revenue, then adapted for companies managing many organizations’ revenue. The seams show in predictable places.
Multi-tenant configuration is the first. Per-client edits, denial handling preferences, appeal templates, fee schedules, and reporting are exactly what a billing company needs to vary. They are often the least configurable part of a platform built for a single organization.
Work queue logic is the second and more consequential. Queue design determines how many claims a biller can work well, which is the company’s cost to collect and therefore its margin. A platform that orders work by age rather than by expected value, and does not let the operation tune that ordering, is capping productivity by design.
Client-facing reporting is the third. Providers renew on visibility, and a generic report is a generic relationship.
The test to apply is narrow and useful: which of these constraints costs real money each month, and is any of it configurable? Frustration that is configurable is not a reason to build.
The Hybrid: License the Plumbing, Build the Workflow
For most billing companies with a genuine reason to build, the right shape is the same: license the transaction and connectivity layer, build the workflow layer above it. This is the RCM platform decision framework that protects budgets.
In practice, transaction translation, clearinghouse connectivity, code set data, and standard transaction plumbing are licensed. Someone else maintains them, tracks version changes, and absorbs payer quirks. The denial taxonomy, work queue prioritization, appeal assembly and deadline management, client configuration, and client-facing reporting are built. They are the operation’s actual product.
The economics are favorable in both directions. It removes the most expensive and least differentiating engineering from the project, cuts the timeline substantially, and reduces ongoing regulatory maintenance. Full control stays with the parts that determine cost to collect and client retention.
It requires clean interfaces between the licensed and built layers, and a deliberate decision about which system holds the claim record. Any advisor recommending a full build without costing this alternative alongside it is not protecting the budget. Ask for the hybrid to be priced explicitly, and compare on a multi-year basis.
The regulatory and licensing scope behind these decisions is set out in HIPAA, the No Surprises Act, CMS Price Transparency, ICD-10 and CPT Licensing and False Claims Act Exposure.
The Five Decisions That Destroy RCM Platform Budgets
1. Building the Transaction Layer
Implementing 837 and 835 handling from licensed specifications is the single most expensive avoidable decision in this category. It is months of work, it accumulates payer-specific edge cases indefinitely, and no client has ever chosen a billing company because it wrote its own EDI translator.
2. Skipping the Acknowledgment Layer
It is invisible in a demo, and it is where claims go quiet. A platform that cannot reconcile every submitted claim to an acknowledgment or a remittance is losing money nobody has counted. Far cheaper to build in release one than to retrofit.
3. Discovering Code Set Licensing Late
CPT requires an AMA license for commercial use in software. X12 implementation guides are licensed. Found after a product is built or in market, this is an expensive and awkward conversation.
4. Underestimating Payer Enrollment
Enrollment is per payer and per client, sits outside the project’s control and on the critical path, and is the most common reason a technically complete platform cannot bill on the planned date.
5. Designing Automation Without Compliance Counsel
The line between checking that claims are accurate and altering what is coded is a legal line, not a product one. Automation designed without counsel and then reviewed later gets rebuilt, and the version that shipped meanwhile carries exposure.
What a Good Scoping Engagement Produces
A billing company software strategy engagement should produce concrete outputs an owner can hold a consultant to:
- A layer-by-layer build vs license RCM recommendation with each layer costed both ways.
- A licensing inventory covering every code set, specification, and terminology the platform depends on, with the licensing position confirmed.
- A payer and client analysis: which payers carry the volume, what enrollment each requires, and which client configurations must be supported at launch.
- A denial profile from the company’s own historical data, by volume and recoverable value, because that determines queue design.
- A compliance scope covering business associate obligations, offshore constraints, and an automation boundary reviewed with counsel.
- A first-release definition scoped to one claim’s full journey with exclusions written down.
- A staged budget with visible assumptions, so a change in client count or payer mix can be reasoned about.
The staged budget these decisions shape is detailed in What Does a Custom Medical Billing and Denial Management Platform Cost to Build in 2026?
Red Flags in the Conversation
A fixed price before any discovery. A full-build proposal with no hybrid costed alongside it. Enthusiasm for writing an EDI translator. No mention of the acknowledgment chain. Code set licensing never raised. Payer enrollment priced as a task rather than treated as a critical path item outside the project’s control. Automation described in terms of lifting or maximizing reimbursement, which should end the conversation rather than raise a question.
The quietest signal: no willingness to conclude that licensing an existing platform, or building only one layer, would serve the company better.
The strongest positive signal is a partner who asks for your denial data before proposing anything. A denial profile is the only honest basis for designing the part of the platform that matters most.
Final Thoughts
Billing companies that ask the question layer by layer, licensing the plumbing, building the workflow that determines cost to collect, confirming their licensing position and automation boundary before committing money, either de-risk a build worth doing or discover that a much smaller project delivers most of the value.
If you are weighing a custom claims platform against the system you run today, a structured scoping produces the answer: layer-by-layer costing, a licensing inventory, a denial profile from your own data, and a compliance boundary reviewed with counsel. NewAgeSys delivers that scoping before development begins. Learn more about digital transformation solutions from one of the leading AI software companies in the United States.
